A world-first gonorrhoea vaccine programme will be launched in England to address record-high levels of the sexually transmitted infection, which reached over 85,000 cases in 2023 – the highest since records began in 1918.
The vaccine, 4CMenB, is an existing jab already used against meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis.
